Skip to content

Author

Guobing Chen

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

AI-assisted discovery of an ABCA1/ABCG1 activator for restoring mitophagy and mitigating Alzheimer’s pathology

Defective mitophagy is a key pathological risk of Alzheimer’s disease (AD), yet available pharmacological agents capable of restoring mitophagy remain clinically limited, largely due to the lack of tools for drug screening and target identification. To address this, we introduce an integrated platform with three nove...

Zhi-Peng Ling, Jun-Ping Pan, Xiang-Lu Xiao et al. · 0 citations
Review Open access Jul 2026

Advances in anti-aging Drug research leveraging multi-omics and artificial intelligence

This review systematically elaborates on the pathological characteristics and molecular mechanisms of aging, analyzes the application paradigms of multi-omics in biomarker screening, mechanism elucidation, and high-throughput screening, and discusses the core value and technical bottlenecks of AI in target prediction,...

Li-Juan Gao, Yong-Sheng Qin, Yudai Xu et al. · 0 citations
Open access Aug 2026

ROS‐Responsive Eye Drop for Controlled Release of 20‐Deoxyingenol Improves Diabetic Corneal Healing by Activating Macrophage Autophagy and Metabolic Reprogramming

ABSTRACT Impaired corneal wound healing in diabetes remains a major clinical challenge, driven by defective autophagy, metabolic dysregulation, and sustained inflammation within a high‐reactive oxygen species (ROS) microenvironment. Here, we engineered a ROS‐responsive ocular delivery system based on N1‐(4‐boronobenzyl...

Jiaxin Wu, Wan-Ying Chen, Haijiang Qiu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.